Asia-Pacific Pharmaceutical Plastic Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Asia-Pacific Pharmaceutical Plastic Packaging Market Report is Segmented by Raw Material (Polypropylene, Polyethylene Terephthalate, Low-Density Polyethylene, High-Density Polyethylene, and Other Raw Materials), Product Type (Solid Containers, Dropper Bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials and Ampoules, Cartridges, Syringes, Caps and Closures, and Other Product Types), and Country (China, India, Japan, and Rest of Asia-Pacific). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Asia-Pacific Pharmaceutical Plastic Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia-Pacific Pharmaceutical Plastic Packaging Market Size

Asia-Pacific Pharmaceutical Plastic Packaging Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 15.67 Billion
Market Size (2030) USD 22.36 Billion
CAGR (2025 - 2030) 7.36 %
Market Concentration Low

Major Players

Asia-Pacific Pharmaceutical Plastic Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Pharmaceutical Plastic Packaging Market with other markets in Packaging Industry

Advanced Packaging

Packaging Equipment

Contract Packaging

Overall Packaging

Packaging Customers

Packaging Forms

Asia-Pacific Pharmaceutical Plastic Packaging Market Analysis

The Asia-Pacific Pharmaceutical Plastic Packaging Market size is estimated at USD 15.67 billion in 2025, and is expected to reach USD 22.36 billion by 2030, at a CAGR of 7.36% during the forecast period (2025-2030).

The region's dominance as home to the world's largest plastic producers ensures a steady supply of plastic materials, significantly impacting the sales of plastic packaging in the pharmaceutical sector. In 2023, Asia-Pacific produced over 50% of the world's total plastic output. Coupled with the region's rapidly growing pharmaceutical industry, this sets the stage for robust market growth.

  • The demand for cost-effective and dependable packaging in pharmaceuticals propels the region's plastic packaging market. The diverse range of available monomers caters to various drugs, enhancing plastic's appeal in pharmaceuticals. Moreover, plastic containers increasingly replace glass for drug storage, minimizing breakage risks.
  • Unit-dose packaging solutions, crucial for preventing dosage errors, are driving the demand for plastics in blisters and other formats like stick packs and pouches. Plastic's flexible and rigid packaging versatility offers added advantages for pharmaceutical manufacturers.
  • As vaccine demand surges due to viral outbreaks, there's a corresponding rise in the need for disposable items like syringes and ampoules, driving the region's pharmaceutical plastic packaging market growth.
  • Multinational pharmaceutical companies are expanding in the region, drawn by low manufacturing costs, accessible raw materials, and increasing healthcare spending. For instance, in May 2023, Aurigene Pharmaceutical Services, part of Dr. Reddy's Laboratories, invested USD 40 million to build a new biomanufacturing facility in India, focusing on therapeutic proteins, antibodies, and viral vectors.
  • Government incentives for pharmaceutical production lure manufacturers and positively influence the packaging market. In March 2023, Inden Pharma's joint venture with ALPLA Group signaled its intent to broaden its reach beyond Europe, targeting markets like India and the United States. This expansion aims for a three-fold increase in annual production, targeting 800 million pharmaceutical packaging products over the next five years.

Asia-Pacific Pharmaceutical Plastic Packaging Industry Overview

The Asia-Pacific pharmaceutical plastic packaging market is fragmented. Various local and global pharmaceutical plastic packaging manufacturers have their presence in the Asia-Pacific region to benefit from the easy availability of raw materials and low production and labor costs. The low entry barrier in the region gained popularity among packaging companies to establish their presence in the region.

In April 2024, Berry Global Group Inc. celebrated the first anniversary of its cutting-edge healthcare manufacturing facility and Global Centre of Excellence in India. This new facility bolstered the company's capacity to assist regional healthcare firms and offer expertise in crafting advanced healthcare solutions.

Asia-Pacific Pharmaceutical Plastic Packaging Market Leaders

  1. Gerresheimer AG

  2. Amcor plc

  3. Berry Global Group, Inc.

  4. ALPLA Group

  5. NIPRO EUROPE GROUP COMPANIES

  6. *Disclaimer: Major Players sorted in no particular order
Asia Pacific Pharmaceutical Plastic Packaging Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Asia-Pacific Pharmaceutical Plastic Packaging Market News

  • March 2024: Berry Global Group Inc. celebrated the first anniversary of its groundbreaking child-resistant closure. This closure, equipped with cutting-edge digital technology, is tailored for drug development, clinical trials, research, and academic studies, significantly enhancing medication adherence.
  • February 2024: Shriji Polymers (India) Limited, a prominent player in rigid plastic packaging solutions for the pharmaceutical sector, commemorated a year since its investment in Parekhplast India Limited. This strategic move is poised to bolster Shriji's foothold in the rigid plastic packaging.

Asia-Pacific Pharmaceutical Plastic Packaging Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of the Geopolitical Scenario Impact on the Industry

5. MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Diabetic Patients in the Region Aids the Sales of Disposable Pharmaceutical Plastic Packaging Solutions
    • 5.1.2 Rise in Number of Pharmaceutical Companies in the Region and Easy Availability of Raw Material
  • 5.2 Market Challenges
    • 5.2.1 Stringent Pharmaceutical Regulation for Packaging and Labeling

6. MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polypropylene (PP)
    • 6.1.2 Polyethylene Terephthalate (PET)
    • 6.1.3 Low Density Polyethylene (LDPE)
    • 6.1.4 High Density Polyethylene (HDPE)
    • 6.1.5 Other Raw Materials
  • 6.2 By Product Type**
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Pouches
    • 6.2.7 Vials and Ampoules
    • 6.2.8 Cartridges
    • 6.2.9 Syringes
    • 6.2.10 Caps and Closure
    • 6.2.11 Other Product Types
  • 6.3 By Country***
    • 6.3.1 China
    • 6.3.2 India
    • 6.3.3 Japan

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Amcor PLC
    • 7.1.3 Berry Global Group Inc.
    • 7.1.4 Klockner Pentaplast Group
    • 7.1.5 NIPRO EUROPE GROUP COMPANIES
    • 7.1.6 Bormioli Pharma (Shanghai) Trading Co. Ltd (Bormioli Pharma SpA)
    • 7.1.7 Cole-Parmer Instrument Company LLC
    • 7.1.8 Taisei Medical Co. Ltd
    • 7.1.9 Shandong Pharmaceutical Glass Co. LTD
    • 7.1.10 Lifelong Meditech Private Limited
    • 7.1.11 Hi-Tech Syringes
    • 7.1.12 Cartel Healthcare Pvt. Ltd
    • 7.1.13 Parekhplast India Limited
    • 7.1.14 JSK Plastic Industries
    • 7.1.15 ALPLA Group
    • 7.1.16 Nathan Healthcare Pvt Ltd
  • *List Not Exhaustive

8. INVESTMENT ANALYSIS

9. FUTURE OUTLOOK OF THE MARKET

**Subject to Availability
***In the final report, Other Asian Countries will be studied together as 'Rest of Asia Pacific'.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia-Pacific Pharmaceutical Plastic Packaging Industry Segmentation

The pharmaceutical plastic packaging market encompasses flexible and rigid solutions for storing and packing pharmaceutical products. Stringent regulations and safety requirements for pharmaceuticals heighten the demand for plastic packaging, as it effectively mitigates contamination risks. As new drugs and medications are developed, the sales of pharmaceutical plastic containers surge. During the forecast period, the market is poised for growth, driven by adopting cost-effective, child-resistant, and senior-friendly packaging solutions. Furthermore, introducing eco-friendly plastic materials addresses the sustainability concerns prevalent among pharmaceutical brands.

The Asia-Pacific pharmaceutical plastic packaging market is segmented by raw material (polypropylene, polyethylene terephthalate, low-density polyethylene, high-density polyethylene, and other raw materials), product type (solid containers, dropper bottles, nasal spray bottles, liquid bottles, oral care, pouches, vials and ampoules, cartridges, syringes, caps and closures, and other product types), and country (China, India, Japan, and rest of Asia-Pacific). The report offers market forecasts and size in value (USD) for all the above segments.

By Raw Material Polypropylene (PP)
Polyethylene Terephthalate (PET)
Low Density Polyethylene (LDPE)
High Density Polyethylene (HDPE)
Other Raw Materials
By Product Type** Solid Containers
Dropper Bottles
Nasal Spray Bottles
Liquid Bottles
Oral Care
Pouches
Vials and Ampoules
Cartridges
Syringes
Caps and Closure
Other Product Types
By Country*** China
India
Japan
Need A Different Region or Segment?
Customize Now

Asia-Pacific Pharmaceutical Plastic Packaging Market Research FAQs

How big is the Asia-Pacific Pharmaceutical Plastic Packaging Market?

The Asia-Pacific Pharmaceutical Plastic Packaging Market size is expected to reach USD 15.67 billion in 2025 and grow at a CAGR of 7.36% to reach USD 22.36 billion by 2030.

What is the current Asia-Pacific Pharmaceutical Plastic Packaging Market size?

In 2025, the Asia-Pacific Pharmaceutical Plastic Packaging Market size is expected to reach USD 15.67 billion.

Who are the key players in Asia-Pacific Pharmaceutical Plastic Packaging Market?

Gerresheimer AG, Amcor plc, Berry Global Group, Inc., ALPLA Group and NIPRO EUROPE GROUP COMPANIES are the major companies operating in the Asia-Pacific Pharmaceutical Plastic Packaging Market.

What years does this Asia-Pacific Pharmaceutical Plastic Packaging Market cover, and what was the market size in 2024?

In 2024, the Asia-Pacific Pharmaceutical Plastic Packaging Market size was estimated at USD 14.52 billion. The report covers the Asia-Pacific Pharmaceutical Plastic Packaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Pharmaceutical Plastic Packaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Pharmaceutical Plastic Packaging Industry Report

Statistics for the 2025 Asia-Pacific Pharmaceutical Plastic Packaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Pharmaceutical Plastic Packaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.